130 related articles for article (PubMed ID: 19201825)
21. The 2-aminogluconate isomer of rhizobium sin-1 lipid A can antagonize TNF-alpha production induced by enteric LPS.
Lee HS; Wolfert MA; Zhang Y; Boons GJ
Chembiochem; 2006 Jan; 7(1):140-8. PubMed ID: 16317789
[TBL] [Abstract][Full Text] [Related]
22. Histones: a novel class of lipopolysaccharide-binding molecules.
Augusto LA; Decottignies P; Synguelakis M; Nicaise M; Le Maréchal P; Chaby R
Biochemistry; 2003 Apr; 42(13):3929-38. PubMed ID: 12667084
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of lipopolysaccharide-caused induction of surfactant protein-A gene expression in human alveolar epithelial A549 cells.
Chuang CY; Chen TL; Chen RM
Toxicol Lett; 2009 Dec; 191(2-3):132-9. PubMed ID: 19712733
[TBL] [Abstract][Full Text] [Related]
24. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide.
Figueiredo MD; Salter CE; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):275-80. PubMed ID: 18023485
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of lipopolysaccharide in acetic acid bacteria.
Taniguchi Y; Nishizawa T; Kouhchi C; Inagawa H; Yamaguchi T; Nagai S; Tamura A; Soma G
Anticancer Res; 2006; 26(6A):3997-4002. PubMed ID: 17195448
[TBL] [Abstract][Full Text] [Related]
26. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.
Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Heumann D
J Immunol; 2001 Sep; 167(6):3329-38. PubMed ID: 11544322
[TBL] [Abstract][Full Text] [Related]
27. Electroacupuncture and moxibustion influence the lipopolysaccharide-induced TNF-alpha production by macrophages.
Aoki E; Kasahara T; Hagiwara H; Sunaga M; Hisamitsu N; Hisamitsu T
In Vivo; 2005; 19(3):495-500. PubMed ID: 15875767
[TBL] [Abstract][Full Text] [Related]
28. Zinc protoporphyrin inhibition of lipopolysaccharide-, lipoteichoic acid-, and peptidoglycan-induced nitric oxide production through stimulating iNOS protein ubiquitination.
Chow JM; Lin HY; Shen SC; Wu MS; Lin CW; Chiu WT; Lin CH; Chen YC
Toxicol Appl Pharmacol; 2009 Jun; 237(3):357-65. PubMed ID: 19376148
[TBL] [Abstract][Full Text] [Related]
29. Molecular cloning, chromosomal location, and expression analysis of porcine CD14.
Sanz G; Pérez E; Jiménez-Marín A; Mompart F; Morera L; Barbancho M; Llanes D; Garrido JJ
Dev Comp Immunol; 2007; 31(7):738-47. PubMed ID: 17169425
[TBL] [Abstract][Full Text] [Related]
30. Cytokine stimulation by Pseudomonas aeruginosa--strain variation and modulation by pulmonary surfactant.
Bufler P; Schikor D; Schmidt B; Griese M
Exp Lung Res; 2004; 30(3):163-79. PubMed ID: 15195551
[TBL] [Abstract][Full Text] [Related]
31. Identification of two novel LPS-binding proteins in Kupffer cells: implications in TNF-alpha production.
Thomas P; Lazure DA; Moussa R; Bajenova O; Burke PA; Ganguly A; Forse RA
J Endotoxin Res; 2006; 12(6):352-7. PubMed ID: 17254389
[TBL] [Abstract][Full Text] [Related]
32. Activin A down-regulates the phagocytosis of lipopolysaccharide-activated mouse peritoneal macrophages in vitro and in vivo.
Zhou J; Tai G; Liu H; Ge J; Feng Y; Chen F; Yu F; Liu Z
Cell Immunol; 2009; 255(1-2):69-75. PubMed ID: 19091310
[TBL] [Abstract][Full Text] [Related]
33. Mapping and analysis of the lytic and fusogenic domains of surfactant protein B.
Ryan MA; Qi X; Serrano AG; Ikegami M; Perez-Gil J; Johansson J; Weaver TE
Biochemistry; 2005 Jan; 44(3):861-72. PubMed ID: 15654742
[TBL] [Abstract][Full Text] [Related]
34. Comparison of biologic activities of synthetic lipopentapeptide analogs of bacterial lipoprotein in mice.
Shimizu T; Ohtsuka Y; Yanagihara Y; Kurimura M; Takemoto M; Achiwa K
Mol Biother; 1991 Mar; 3(1):46-50. PubMed ID: 2069759
[TBL] [Abstract][Full Text] [Related]
35. The biological activity of a liposomal complete core lipopolysaccharide vaccine.
Erridge C; Stewart J; Bennett-Guerrero E; McIntosh TJ; Poxton IR
J Endotoxin Res; 2002; 8(1):39-46. PubMed ID: 11981444
[TBL] [Abstract][Full Text] [Related]
36. Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses.
Geurtsen J; Fransen F; Vandebriel RJ; Gremmer ER; de la Fonteyne-Blankestijn LJ; Kuipers B; Tommassen J; van der Ley P
Vaccine; 2008 Feb; 26(7):899-906. PubMed ID: 18207288
[TBL] [Abstract][Full Text] [Related]
37. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides.
Rosenfeld Y; Sahl HG; Shai Y
Biochemistry; 2008 Jun; 47(24):6468-78. PubMed ID: 18498177
[TBL] [Abstract][Full Text] [Related]
38. Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein.
Wasiluk KR; Leslie DB; Vietzen PS; Mayo KH; Dunn DL
Surgery; 2004 Aug; 136(2):253-60. PubMed ID: 15300188
[TBL] [Abstract][Full Text] [Related]
39. Combined cell wall polysaccharide, mycotoxin and bacterial lipopolysaccharide exposure and inflammatory cytokine responses.
Johannessen L; Løvik M; Lydersen S; Nilsen AM
APMIS; 2009 Jul; 117(7):507-17. PubMed ID: 19594491
[TBL] [Abstract][Full Text] [Related]
40. Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity.
Nan YH; Bang JK; Shin SY
Peptides; 2009 May; 30(5):832-8. PubMed ID: 19428758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
